//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
ET Markets
12,248.2567.9
Stock Analysis, IPO, Mutual Funds, Bonds & More

Jubilant Life Sciences Ltd.

ET 500

Rank 2019
171
ENGNew
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்
  • NSE
    15:59 | 24-01-2020
  • BSE
    15:54 | 24-01-2020
621.70

Today's Change

-14.75 (-2.32%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

153,333

Open

636.45

Prev. Close

636.45

Day's Trend

  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)1.00
  • EPS-TTM (Rs.)13.78
  • BV/share (₹)301.92
  • 52Wk L/H391.05/ 898.85
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsEvents| Recos| Updates| News| Speed
Buy Jubilant Life, target Rs 867: Anand Rathi| Recos
Buy
Jubilant Life Sciences Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Jubilant Life Sciences Ltd.Schedule Of Investor Conference Call For Jubilant Life Sciences Limited - Unaudited Financial Results For The Quarter En...| Announcement
Jubilant Life Sciences Ltd.Board Meeting Intimation for Intimation Of Board Meeting - January 31, 2020| Announcement
Jubilant Life Sciences Ltd.Shareholding for the Period Ended December 31, 2019| Announcement
Jubilant Life Sciences Ltd.Intimation Pursuant To Regulation 57(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015| Announcement
Jubilant Life Sciences Ltd.Early Redemption Of Non-Convertible Debentures| Announcement
Jubilant Life Sciences Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Jubilant Life Sciences Ltd.Closure of Trading Window| Announcement
Jubilant Life Sciences Ltd.Intimation Pursuant To Regulation 29, Regulation 50(1) And 60(2) Of The SEBI (Listing Obligations And Disclosure Require...| Announcement
Jubilant Life Sciences Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
Jubilant Life Sciences Ltd.Securities Appellate Tribunal Order| Announcement
Jubilant Life Sciences Ltd.Announcement under Regulation 30 (LODR)-Credit Rating| Announcement
Jubilant Life Sciences Ltd.Announcement under Regulation 30 (LODR)-Credit Rating| Announcement
Jubilant Life Sciences Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Jubilant Life Sciences Ltd.Announcement under Regulation 30 (LODR)-Scheme of Arrangement| Announcement
Jubilant Life Sciences Ltd.Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regardi...| Announcement
Jubilant Life Sciences Ltd.Compliance With Regulation 52(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015| Announcement
Jubilant Life Sciences Ltd.Announcement under Regulation 30 (LODR)-Change in Management| Announcement
Jubilant Life Sciences Ltd.Results For The Quarter And Half Year Ended September 30, 2019| Announcement
Jubilant Life Sciences Ltd.Certificate Obtained From A Practising Company Secretary For The Period Ended September 30, 2019| Announcement
Jubilant Life slips 4% on USFDA inspection| News
Jubilant Life Sciences Ltd. share price down by -2.32% from its previous close of Rs 636.45. Jubilant Life Sciences Ltd. stock last traded price is 621.70
Jubilant Life Sciences Ltd. Share Price
Value
Today/Current/Last
621.70
Previous Day
636.45
What's your view on Jubilant Life Sciences for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Jubilant Life Sciences Ltd.

Jubilant Life Sciences Ltd.
Quarterly Results

Figures in Rs. Cr
Sep 2019 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
2,236.55
3.89
-0.40
0.00
8123.35
Other Operating Income
29.38
1.03
22.83
0.00
174.16
Operating Profit
468.45
7.79
4.06
-62.92
2640.87
Other Income
12.26
26.39
220.10
-1.24
200.85
EBITDA
480.71
8.19
5.88
-62.92
2640.87
Interest
71.64
-1.30
14.22
0.00
116.00
Depreciation
116.84
13.78
30.58
0.00
473.28
Tax
42.84
-49.03
-53.46
-320.70
266.03
Net Profit
249.39
34.82
18.53
-127.07
1106.80
EPS (₹)
15.66
34.88
16.00
-12.25
66.68

Jubilant Life Sciences Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
621.70
-2.32
9.19
18.41
9.32
-14.03
-10.50
275.76
18.35
4.86
-93.97
-93.90
-93.76
-90.94
-89.39
-91.44
350.75
-0.04
-2.56
-0.31
15.28
-46.02
-59.90
-51.57
185.85
0.62
-1.48
17.33
45.76
8.08
-43.35
-44.48
412.05
-0.69
1.52
11.88
18.87
9.09
-13.71
0.00
509.55
0.51
0.74
9.58
18.03
-23.83
0.00
0.00
307.25
0.74
-1.24
-1.43
-6.91
4.35
9.13
0.00
1180.25
-0.22
3.82
23.75
18.56
1.34
-32.67
22.95
589.85
0.18
-1.96
7.99
8.65
0.22
0.85
23.44
1224.15
-0.19
-0.87
6.27
25.83
56.07
122.19
91.63
660.15
1.72
5.55
15.24
12.92
-3.00
3.25
142.30
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Jubilant Life Sciences Ltd Risk Return Comparison

with peersNew

Jubilant Life Sciences Ltd
Financial Comparison

with peers
Management Efficiency
Jubilant Life Sciences Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
11.94
8.88
-99.01
47.57
Return on Assets (%)
5.05
5.56
-27.48
26.25
Return on capital Employed (%)
10.99
6.02
-130.86
23.01
Fixed Assets Turnover (x)
1.08
-1.92
-193.68
2.79
Profitability and Growth
Gross Profit Margin (%)
15.01
-8.25
-980.00
34.42
Operating Profit Margin(%)
19.08
0.75
-896.19
37.94
Net Profit margin (%)
6.30
1.90
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
1.69
1.62
0.08
9.50
Current Ratio (x)
2.51
2.36
0.21
9.50
Cash ratio (x)
0.71
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.88
0.28
0.00
2.65
Coverage Ratios
Cash flows to long term debt (x)
3.86
3.89
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Jubilant Life Sciences Ltd Share Holding as on 31-12-2019

CategoryNo. of sharesPercentage
Promoters74,086,67646.51
ForeignInstitutions43,697,52527.43
GeneralPublic21,224,29313.33
Others9,419,6815.91
ForeignPromoter6,630,3804.16
NBanksMutualFunds3,550,2252.23
FinancialInstitutions672,3590.42

MF Ownership Of Jubilant Life Sciences Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
Equity: Large & MidCap
995497
0.00%
1%
53.46
Canara Robeco Equity Hybrid Direct-G
Portfolio as on 31-12-2019
Hybrid: Aggressive Hybrid
244749
0.00%
0.47%
13.14
DSP Healthcare Fund Direct-G
Portfolio as on 31-12-2019
Equity: Sectoral-Pharma
188011
0.00%
4.15%
10.10

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Jubilant Life Sciences Ltd.

Jubilant Life Sciences Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 9895.34 Crore) operating in Pharmaceuticals sector.

Jubilant Life Sciences Ltd. key Products/Revenue Segments include Organic Chemicals which contributed Rs 3391.46 Crore to Sales Value (98.62 % of Total Sales), Other Operating Revenue which contributed Rs 45.23 Crore to Sales Value (1.31 % of Total Sales) and Sale of services which contributed Rs 1.92 Crore to Sales Value (0.05 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 2236.55 Crore, up 3.89 % from last quarter Sales of Rs 2152.78 Crore and down -.40 % from last year same quarter Sales of Rs 2245.57 Crore Company has reported net profit after tax of Rs 249.39 Crore in latest quarter.

The company’s top management includes Dr.Ashok Misra, Mr.Anant Pande, Mr.Arjun Shanker Bhartia, Mr.Arun Seth, Mr.Hari S Bhartia, Mr.Priyavrat Bhartia, Mr.Rajesh Kumar Srivastava, Mr.S Sridhar, Mr.Shyam S Bhartia, Mr.Sushil Kumar Roongta, Mr.Vivek Mehra, Ms.Sudha Pillai. Company has B S R & Co. LLP as its auditoRs As on 31-12-2019, the company has a total of 159,281,139 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors